Kamada (KMDA) Net Income (2012 - 2026)
Kamada (KMDA) posted quarterly Net Income of $4.1 million for Q1 2026, up 4.24% year-on-year from $4.0 million in Q1 2025, and up 16.0% on a QoQ basis from $3.6 million in Q4 2025.
Kamada (KMDA) Net Income (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Net Income for 15 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.
- Quarterly Net Income rose 4.24% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.4 million (up 26.8% YoY) and the FY2025 annual result came in at $20.2 million, up 39.66% from the prior year.
- Net Income rose to $4.1 million in Q1 2026 per KMDA's latest filing, from $3.6 million in the prior quarter.
- Over the last five years, Net Income for KMDA reached as high as $7.4 million in Q2 2025 and fell as low as $484.0 in Q3 2022.
- A 5-year average of $3.2 million and a median of $3.8 million in 2024 frame the typical range for Net Income.
- Annual changes were most pronounced in 2022 — Net Income tumbled 99.94% — and 2023, when it jumped 665809.09%.
- Year by year, Net Income stood at $2944.0 in 2022, then jumped by 171707.07% to $5.1 million in 2023, then retreated by 24.71% to $3.8 million in 2024, then dropped by 6.46% to $3.6 million in 2025, then advanced by 16.0% to $4.1 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered $4.1 million, $3.6 million, and $5.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 4.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.13 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 7.38 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Jun 30, 2024 | 4.43 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1,809.00 |
| Dec 31, 2022 | 2,944.00 |
| Sep 30, 2022 | 484.00 |
| Jun 30, 2022 | 3.92 Mn |
| Mar 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 5,009.00 |
| Sep 30, 2021 | 845,000.00 |
| Jun 30, 2021 | 937,000.00 |